About Delex Healthcare Group
Delex Healthcare Group is a private company based in New York, New York. It has reported $0 raised in four offerings on Form D since March 2022. Its chief executive is J. de Ruyter Oroceo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Apr 14, 2023 | $0target not set | 0 | — | EquityRule 506(c) | Form D ↗ |
| Not yet | Apr 14, 2023 | $0target not set | 0 | — | EquityRule 506(b) | Form D ↗ |
| Not yet | Mar 31, 2022 | $0of $20.0M target | 0 | — | EquityRule 506(c) | Form D ↗ |
| Not yet | Mar 29, 2022 | $0of $20.0M target | 0 | — | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $0 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Delex Healthcare Group's Form D filed Apr 14, 2023.
Earlier filings also listed Noel Omandam (executive officer and director, last listed Mar 2022), Ma. Lourdes Elvira Monasterio (executive officer and director, last listed Mar 2022), Ana Lyn Matienzo (executive officer and director, last listed Mar 2022) and Allery Flores (executive officer and director, last listed Mar 2022).